ENHANCED TAQMAN PROBE BASED AMPLIFICATION

• US 20110300544A1
• Filed: 12/07/2009
• Published: 12/08/2011
• Est. Priority Date: 12/09/2008
• Status: Abandoned Application

• Current Assignee: Oxitec Limited (Precigen, Inc.)
• Original Assignee: Oxitec Limited (Precigen, Inc.)
• Inventors: Fu, Guoliang
• Application Number:
  US13/133,893
• Publication Number:
  US 20110300544A1
• Time in Patent Office: Days
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2537/162 Helper probe
• CPC Class Codes: C12Q 2561/101 Taqman

Abstract

The present invention relates to the field of amplification and detection. In particular, the invention relates to methods for assaying a sample for one or more nucleic acid targets in a single reaction based on target amplification using a polymerase with 5′ nuclease activity. The invention also provides probes and kits for use in such method.

Claims

1. A method for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising:

(a) providing to an amplification assay containing said sample;

(i) a pair of amplification primers,

wherein the first amplification primer contains a sequence complementary to a region of one strand of the target nucleic acid and is capable of priming the synthesis of the complementary strand,

and wherein the second primer contains a sequence complementary to a region of the second strand of the target nucleic acid and is capable of priming the synthesis of a strand which is complementary thereto,

such that, upon amplification in the presence of the target nucleic acid, the stretch of target nucleic acid between the amplification primers is amplified;

(ii) a helper oligonucleotide containing a sequence complementary to a first region of the target nucleic acid;

(iii) a labelled oligonucleotide containing a sequence complementary to a second region of the target nucleic acid;

wherein the helper oligonucleotide and the labelled oligonucleotide both anneal to the same strand of the target nucleic acid,

wherein the second region is adjacent to 5′

end of the first region, or partially including the first region, and

wherein the helper oligonucleotide and the labelled oligonucleotide both anneal within the target nucleic acid sequence bound by the amplification primers,

wherein

if the target nucleic acid is present in the sample, the helper oligonucleotide and the labelled oligonucleotide anneal to the target nucleic acid such that the 3′

end of the helper oligonucleotide is adjacent to or overlaps the 5′

end of the labelled oligonucleotide,

(b) carrying out an amplification reaction using a nucleic acid polymerase having 5′

nuclease activity

under conditions which would, if the target nucleic acid is present in the sample, be permissive for the steps of;

(i) hybridising the amplification primers, helper oligonucleotide and labelled oligonucleotide to the target nucleic acid,

wherein the 5′

nuclease activity of the polymerase cleaves the annealed, labelled oligonucleotide, in a polymerisation independent manner, to release labelled fragments which are detectable; and

(ii) extending the amplification primers, wherein the nucleic acid polymerase synthesizes primer extension products; and

(c) detecting and/or measuring the release of labelled fragments to determine the presence or absence or amount of the target nucleic acid sequence in the sample.

2. The method of claim 1, wherein the annealed helper oligonucleotide facilities the hybridisation of the labeled oligonucleotide and/or enhances the cleavage of the annealed, labeled oligonucleotide, wherein the hybridising condition and/or extending condition permits the 5′

nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments.

3. The method of claim 1, wherein the cleavage of the labeled oligonucleotide occurs during extension of the amplification.

4. The method of claim 1, wherein the hybridising and extending occur in the same conditions.

5. The method of claim 1, wherein the hybridising condition and the extending condition are repeated at least once in a single round of thermal cycling, if the hybridising and the extending conditions are not the same conditions.

6. The method of claim 1, wherein the 3′

end of the helper oligonucleotide in the annealed duplex is adjacent to the 5′

end of an annealed, labeled oligonucleotide, having spacing effective to permit the cleavage of the labeled oligonucleotide in the absence of nucleic acid polymerisation,

wherein said spacing between the 3′

end of the helper oligonucleotide in the annealed duplex and the 5′

end of an annealed, labeled oligonucleotide is from 0 to 10 nucleotides.

7. The method of claim 1, wherein the 3′

end of the helper oligonucleotide in the annealed duplex overlaps the 5′

end of an annealed, labeled oligonucleotide, having overlapping region effective to permit the cleavage of the labeled oligonucleotide in the absence of nucleic acid polymerisation,

wherein said overlapping region between the 3′

end of the helper oligonucleotide in the annealed duplex and the 5′

end of an annealed, labeled oligonucleotide has 1 to 15 nucleotides.

8. The method of claim 1, wherein the 3′

end of the helper oligonucleotide in the annealed duplex has a single nucleotide at 3′

terminus not complementary to the target nucleic acid sequence.

9. The method of claim 1, wherein the labeled oligonucleotide comprises at least one label,

wherein the labeled oligonucleotide comprises first and second labels wherein the first label is separated from the second label by a nuclease susceptible cleavage site.

10. The method of claim 1, wherein the helper oligonucleotide is not extended during amplification.

11. The method of claim 1, wherein said labeled oligonucleotide is a single-stranded double-dye labeled TaqMan probe, or is a molecular beacon probe, or is one of strands of a partially double stranded probe, wherein said partially double-stranded probe comprises first oligonucleotide which is capable of hybridising to second oligonucleotide, wherein each of first and second oligonucleotides comprises a member of interactive label pair.

15. The method of claim 1, wherein the amplification is a polymerase chain reaction (PCR), wherein the hybridisation and the extension conditions are repeated at least once in a single round of thermal cycling if the hybridisation and the extension conditions are not the same conditions, wherein said single round of thermal cycling comprises temperatures for denaturing, hybridising, extending, hybridising and extending.

16. The method of claim 1, wherein the amplification is an isothermal amplification.

12. A method for monitoring nucleic acid amplification comprising:

(a) providing to an amplification assay containing said sample;

(i) a pair of amplification primers,

wherein the first amplification primer contains a sequence complementary to a region of one strand of the target nucleic acid and is capable of priming the synthesis of the complementary strand,

and wherein the second primer contains a sequence complementary to a region of the second strand of the target nucleic acid and is capable of priming the synthesis of a strand which is complementary thereto,

such that, upon amplification in the presence of the target nucleic acid, the stretch of target nucleic acid between the amplification primers is amplified;

(ii) a set of multiple labeled oligonucleotides, wherein each of the labeled oligonucleotides anneals to the same strand of the target nucleic acid,

wherein all the labeled oligonucleotides anneal within the target nucleic acid sequence bound by the amplification primers,

wherein

if the target nucleic acid is present in the sample, the labeled oligonucleotides anneal to the target nucleic acid such that the 3′

end of one of the labeled oligonucleotide is adjacent to or overlaps the 5′

end of a downstream labeled oligonucleotide, one of the amplification primers is adjacent to or overlaps the 5′

end of a downstream labeled oligonucleotide;

(b) carrying out an amplification reaction using a nucleic acid polymerase having 5′

nuclease activity under conditions which would, if the target nucleic acid is present in the sample, be permissive for the steps of;

(i) hybridising the amplification primers, labeled oligonucleotides to the target nucleic acid,

wherein the annealed upstream labeled oligonucleotide acts as helper oligonucleotide, facilities the hybridisation of the downstream labeled oligonucleotide and/or enhances the cleavage of the annealed, labeled oligonucleotide by the 5′

nuclease activity of the polymerase, in a polymerisation independent manner, to release labeled fragments which are detectable; and

(ii) extending the amplification primers, wherein the nucleic acid polymerase synthesizes primer extension products,

wherein the hybridising condition and/or extending condition permits the 5′

nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and

(c) detecting and/or measuring the release of labeled fragments to determine the presence or absence or amount of the target nucleic acid sequence in the sample.

18. The method of claim 12, wherein the amplification is a polymerase chain reaction (PCR), wherein the hybridisation and the extension conditions are repeated at least once in a single round of thermal cycling if the hybridisation and the extension conditions are not the same conditions, wherein said single round of thermal cycling comprises temperatures for denaturing, hybridising, extending, hybridising and extending.

19. The method of claim 12, wherein the amplification is an isothermal amplification.

13. A method for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising:

(a) contacting a sample comprising single-stranded nucleic acids with an first oligonucleotide primer containing a sequence complementary to a first region of the target nucleic acid and a labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, overlapping the first region defined by the first oligonucleotide primer, to create a mixture of duplexes during hybridization conditions, if the target nucleic acid sequence is present in the sample, wherein the duplexes comprise the target nucleic acid annealed to the first oligonucleotide primer and to the labeled oligonucleotide such that the 3′

end of the first oligonucleotide primer overlaps the 5′

end of the labeled oligonucleotide;

(b) maintaining the mixture of step (a) with a template-dependent nucleic acid polymerase having a 5′

to 3′

nuclease activity under conditions sufficient to permit the 5′

nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and

(c) detecting and/or measuring the release of labeled fragments and thereby detecting and/or measuring the target nucleic acid in the sample.

wherein the 3′

end of the first oligonucleotide primer in the annealed duplex of step (a) overlaps the 5′

end of an annealed, labeled oligonucleotide, having overlapping length effective to permit the release of labeled fragments in the absence of nucleic acid polymerisation.

14. The method of claim 13 performed under extension conditions sufficient to promote nucleic acid polymerization, wherein the release of labeled fragments occurs during extension of the first oligonucleotide primer.

20. The method of claim 13, wherein the amplification is a polymerase chain reaction (PCR), wherein the hybridisation and the extension conditions are repeated at least once in a single round of thermal cycling if the hybridisation and the extension conditions are not the same conditions, wherein said single round of thermal cycling comprises temperatures for denaturing, hybridising, extending, hybridising and extending.

21. The method of claim 13, wherein the amplification is an isothermal amplification.

17. A kit for detecting a nucleic acid sequence in a sample comprising:

(a) a set of oligonucleotide primers, wherein a first primer contains a sequence complementary to a region in one strand of the nucleic acid sequence and primes the synthesis of a first extension product, and a second primer contains a sequence complementary to a region in said first extension product and primes the synthesis of a nucleic acid strand complementary to said first extension product, and wherein each oligonucleotide primer is selected to anneal to its complementary template upstream of any labeled oligonucleotide annealed to the same nucleic acid strand,

(b) at least one helper oligonucleotide containing a sequence complementary to a region of the target nucleic acid and at least one labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, but not including or partially including the nucleic acid defined by the helper oligonucleotide, wherein said helper oligonucleotide and said labeled oligonucleotide are capable of hybridising to the target sequence to create duplexes during hybridisation conditions, wherein the duplexes comprise the target nucleic acid annealed to the helper oligonucleotide and to the labeled oligonucleotide such that the 3′

end of the helper oligonucleotide is adjacent to or overlaps with the 5′

end of the labeled oligonucleotide, wherein said helper oligonucleotide and said labeled oligonucleotide anneals within the target nucleic acid sequence bound by the amplification primers of part (a), wherein said labeled oligonucleotide is blocked at the 3′

terminus to prohibit incorporation of said labeled oligonucleotide into a primer extension product,

wherein said blocking is achieved by adding a chemical moiety to the 3′

hydroxyl of the last nucleotide,

wherein said labeled oligonucleotide and said helper oligonucleotide anneal within the nucleic acid sequence concurrently with each oligonucleotide primer priming the synthesis of the first extension product or the nucleic acid strand complementary to the first extension product,

wherein said labeled oligonucleotide is blocked at the 3′

terminus by removing the 3′

-hydroxyl from said labeled oligonucleotide.